Acceleration of the cerebral dopamine turnover by chlorpromazine.
D000818:Animals; D001921:Brain / Q000187:drug effects* / Q000378:metabolism*; D002746:Chlorpromazine / Q000494:pharmacology*; D004298:Dopamine / Q000378:metabolism*; D005470:Fluorometry; D006168:Guinea Pigs; D006897:Hydroxyindoleacetic Acid / Q000378:metabolism*; D007490:Iproniazid / Q000494:pharmacology; D010293:Pargyline / Q000494:pharmacology; D010648:Phenylacetates / Q000378:metabolism*; D051381:Rats
D010648:Phenylacetates; D006897:Hydroxyindoleacetic Acid; D010293:Pargyline; D007490:Iproniazid; D002746:Chlorpromazine; D004298:Dopamine